Galembikova Aigul

16PUBLICATIONS
37CO-AUTHORS
Molecular targetsComputational physiologyImmunogenetics (incl. genetic immunology)Nutrigenomics and personalised nutritionGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 16, 2026
Re-Evaluating Multi-Kinase Inhibitors Targeting FGFR and VEGFR Pathways for Combined Therapy in Colorectal Cancer: A Preclinical Study.

|Jan 10, 2026
Hypoxia-Inducible Factor-1α, a Novel Molecular Target for a 2-Aminopyrrole Derivative: Biological and Molecular Modeling Study.

Svetlana S Zykova, Tatyana Gessel, Aigul Galembikova

|Sep 13, 2025
Claudin-1 Contributes to Gastrointestinal Stromal Tumors (GIST) Resistance to Imatinib Mesylate (IM) via Regulation of FGFR-Signaling.

Sergei Boichuk, Firyuza Bikinieva, Pavel Dunaev

|Apr 17, 2025
Enhancement of NK Cell Cytotoxic Activity and Immunoregulatory Effects of a Natural Product Supplement Across a Wide Age Span: A 30-Day In Vivo Human Study.

Sergei Boichuk, Aigul Galembikova, David Vollmer

|Sep 14, 2024
Fibroblast Growth Factor 2 (FGF2) Activates Vascular Endothelial Growth Factor (VEGF) Signaling in Gastrointestinal Stromal Tumors (GIST): An Autocrine Mechanism Contributing to Imatinib Mesylate (IM) Resistance.

Sergei Boichuk, Pavel Dunaev, Aigul Galembikova

|Apr 27, 2024
Imbalance between Actin Isoforms Contributes to Tumour Progression in Taxol-Resistant Triple-Negative Breast Cancer Cells.

Vera Dugina, Maria Vasileva, Natalia Khromova

Pageof 3

Frequent Collaborators

15 joint publications

Sergei V Boichuk

8 joint publications

Firyuza Bikinieva

6 joint publications

Pavel Kopnin

5 joint publications

Pavel Dunaev